Tempest Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
TPST on Nasdaq
Location
2000 Sierra Point Parkway, Suite 400, Brisbane, CA

Insiders trading volume in the past year

Tempest Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Versant Vantage II, L.P. 10%+ Owner $10.1M Apr 29, 2022
Versant Venture Capital VI, L.P. 10%+ Owner $2.56M -$967K -27.4% Aug 8, 2024
Rock Springs Capital Management LP 10%+ Owner $352K Dec 30, 2021
Stephen R. Brady President and CEO, Director $97.9K +$73.9K +308% Jul 3, 2024
Justin Trojanowski Corporate Controller $47.9K +$16.2K +51.1% Jun 28, 2024
Samuel Whiting Chief Medical Officer $20.4K +$9.95K +95.3% Jul 2, 2024
Nicholas Maestas VP of Strategy and Finance Jan 3, 2024
Pierre Lorenzo Corporate Controller Jun 21, 2022
Thomas W. Dubensky President, Director Jan 3, 2023
Christine A. Pellizzari Director Jun 13, 2024
Michael Raab Director Jun 13, 2024
Geoffrey Nichol Director Jun 13, 2024
Ronit Simantov Director Jun 13, 2024
Thomas Woiwode Director Jun 17, 2022
Stella Xu Director Jul 1, 2021

Recent Insider Transactions by Companies or Individuals for Tempest Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.